JP2008501649A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501649A5
JP2008501649A5 JP2007513783A JP2007513783A JP2008501649A5 JP 2008501649 A5 JP2008501649 A5 JP 2008501649A5 JP 2007513783 A JP2007513783 A JP 2007513783A JP 2007513783 A JP2007513783 A JP 2007513783A JP 2008501649 A5 JP2008501649 A5 JP 2008501649A5
Authority
JP
Japan
Prior art keywords
group
compound
formula
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007513783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501649A (ja
JP4594386B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/005594 external-priority patent/WO2005117865A1/en
Publication of JP2008501649A publication Critical patent/JP2008501649A/ja
Publication of JP2008501649A5 publication Critical patent/JP2008501649A5/ja
Application granted granted Critical
Publication of JP4594386B2 publication Critical patent/JP4594386B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007513783A 2004-06-02 2005-05-24 ヒスタミン3受容体のリガンドとして有用なナフタレン誘導体 Expired - Fee Related JP4594386B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102460 2004-06-02
PCT/EP2005/005594 WO2005117865A1 (en) 2004-06-02 2005-05-24 Naphthaline derivatives useful as histamine-3-receptor ligands

Publications (3)

Publication Number Publication Date
JP2008501649A JP2008501649A (ja) 2008-01-24
JP2008501649A5 true JP2008501649A5 (enExample) 2010-09-24
JP4594386B2 JP4594386B2 (ja) 2010-12-08

Family

ID=34982058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007513783A Expired - Fee Related JP4594386B2 (ja) 2004-06-02 2005-05-24 ヒスタミン3受容体のリガンドとして有用なナフタレン誘導体

Country Status (24)

Country Link
US (2) US7259158B2 (enExample)
EP (1) EP1755593B1 (enExample)
JP (1) JP4594386B2 (enExample)
KR (1) KR100854212B1 (enExample)
CN (1) CN1960727B (enExample)
AR (1) AR049433A1 (enExample)
AT (1) ATE383857T1 (enExample)
AU (1) AU2005249196B2 (enExample)
BR (1) BRPI0511778A (enExample)
CA (1) CA2566526C (enExample)
DE (1) DE602005004404T2 (enExample)
DK (1) DK1755593T3 (enExample)
ES (1) ES2299074T3 (enExample)
IL (1) IL179370A (enExample)
MX (1) MXPA06014017A (enExample)
MY (1) MY139704A (enExample)
NO (1) NO20065733L (enExample)
NZ (1) NZ550764A (enExample)
PL (1) PL1755593T3 (enExample)
PT (1) PT1755593E (enExample)
RU (1) RU2387638C2 (enExample)
TW (1) TWI299992B (enExample)
WO (1) WO2005117865A1 (enExample)
ZA (1) ZA200609678B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5520479B2 (ja) 2006-02-20 2014-06-11 コニカミノルタ株式会社 有機エレクトロルミネッセンス素子、白色発光素子、及び照明装置
US8012955B2 (en) * 2006-12-28 2011-09-06 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
EA019031B1 (ru) 2007-05-03 2013-12-30 Сефалон, Инк. Способ получения 6-{4-[3-((r)-2-метилпирролидин-1-ил)пропокси]фенил}-2н-пиридазин-3-она и его фармацевтически приемлемой соли
JP5544296B2 (ja) 2007-11-16 2014-07-09 ライジェル ファーマシューティカルズ, インコーポレイテッド 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
ES2553340T3 (es) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
MX2010011288A (es) 2008-04-23 2010-11-09 Rigel Pharmaceuticals Inc Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
JP5833105B2 (ja) 2010-05-11 2015-12-16 サノフイ 置換n−ヘテロアリールスピロラクタムビピロリジン類、その製造及び治療的使用
TW201206910A (en) * 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
AR081034A1 (es) 2010-05-11 2012-05-30 Sanofi Aventis Derivados de n-heteroaril tetrahidro-isoquinolina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central
WO2011143162A1 (en) 2010-05-11 2011-11-17 Sanofi Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
JP5766278B2 (ja) 2010-05-11 2015-08-19 サノフイ 置換されたn−アルキルおよびn−アシルテトラヒドロ−イソキノリン誘導体、それらの製造および治療上の使用
TW201206939A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
KR101408699B1 (ko) 2012-02-29 2014-06-19 중앙대학교 산학협력단 지르코늄 선택적 형광 프루브
ES2684995T3 (es) 2012-07-27 2018-10-05 Biogen Ma Inc. Derivados del ácido 2-(1-(1-(6-((ciclohexil)oxi)-5-(trifluorometil)naftalen-2-il)etil)piperidin-3-il)acético como moduladores de la autotaxina (atx) para el tratamiento de inflamaciones y trastornos autoinmunes
NZ703851A (en) * 2012-07-27 2017-01-27 Biogen Ma Inc Compounds that are s1p modulating agents and/or atx modulating agents
PL2888243T3 (pl) * 2012-08-23 2017-01-31 Suven Life Sciences Limited Związki akryloamidowe jako ligandy receptora histaminowego H3
CN117229207B (zh) * 2023-09-01 2024-09-03 浙江工业大学 一种苯基萘类化合物及其制备与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
KR20000016147A (ko) * 1996-05-31 2000-03-25 로렌스 티. 마이젠헬더 선택적 도파민 d3 리간드로서의 아릴 치환된 시클릭 아민
CA2441080A1 (en) * 2001-03-23 2002-10-03 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224557D0 (en) * 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
WO2004043458A1 (en) * 2002-11-12 2004-05-27 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
BRPI0518222A (pt) * 2004-10-19 2008-11-04 Hoffmann La Roche composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos

Similar Documents

Publication Publication Date Title
JP2008501649A5 (enExample)
JP2007500753A5 (enExample)
RU2011129383A (ru) Производное амина, обладающее антагостической активностью в отношении рецептора npy y5
JP2005527336A5 (enExample)
JP2005514410A5 (enExample)
JP2005523310A5 (enExample)
JP2009541415A5 (enExample)
JP2009541403A5 (enExample)
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
EP2085388A4 (en) NEW 1,2-DIHYDROCHINOLINE DERIVATIVE WITH SUBSTITUTED PHENYLAMINOENE ALKYL GROUP AND PHENYL GROUP INTRODUCED BY AN ESTER AS SUBSTITUENTS
JP2010520851A5 (enExample)
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
JP2008519084A5 (enExample)
JP2004535380A5 (enExample)
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
JP2009075520A5 (enExample)
TW200745039A (en) Isotopically substituted pantoprazole
JP2001354766A5 (enExample)
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
HRP20110780T1 (hr) Aminoarilsulfonamidni spojevi i njihova upotreba kao ligandi 5-ht6
JP2008501844A5 (enExample)
JP2003504349A5 (enExample)
DE602006001330D1 (de) Herstellung von 1-(Alkoxysilyl)ethyl-1,1,3,3-tetramethyldisiloxan
IS8007A (is) 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer